Format

Send to

Choose Destination
Climacteric. 2017 Dec;20(6):577-582. doi: 10.1080/13697137.2017.1377696. Epub 2017 Oct 5.

FSH to estradiol ratio can be used as screening method for mild cognitive impairment in postmenopausal women.

Author information

1
a Department of Obstetrics and Gynecology , Reproductive Immunoendocrinology Division, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital , Jakarta , Indonesia.
2
b Department of Psychiatry, Faculty of Medicine Universitas Indonesia , Cipto Mangunkusumo Hospital , Jakarta , Indonesia.
3
c Department of Physiology, Faculty of Medicine Universitas Indonesia , Jakarta , Indonesia.
4
d Department of Neurology, Faculty of Medicine Universitas Indonesia , Cipto Mangunkusumo Hospital , Jakarta , Indonesia.

Abstract

OBJECTIVE:

To determine the role of anthropometric measurement, menopausal symptoms and biochemical marker changes as screening methods for mild cognitive impairment (MCI) in postmenopausal women Methods: A cross-sectional study included 282 postmenopausal women in Jakarta, further classified into two groups, with and without MCI. Some related variables such as age, body mass index (BMI), duration of menopause, vasomotor symptoms, hormone levels such as follicle stimulating hormone (FSH), luteinizing hormone, leptin, estradiol, and cognitive status, were assessed and analyzed.

RESULTS:

The FSH levels significantly correlated with MCI incidence (p = 0.018), along with the ratio of FSH/estradiol levels (p = 0.029) and ratio of FSH/soluble leptin receptor (p = 0.011), while other variables did not. By multivariate analysis, the ratio of FSH/estradiol was known as the most significant factor with a probability of having MCI in menopausal women of 1.15. Using the ROC curve, the threshold of the ratio FSH/estradiol to predict MCI was 1.94, with sensitivity 66.5% and specificity 46.8%.

CONCLUSIONS:

The ratio of FSH to estradiol (>1.94) can be used as a screening method for the occurrence of MCI in postmenopausal women.

KEYWORDS:

FSH; Menopause; mild cognitive impairment

PMID:
28980489
DOI:
10.1080/13697137.2017.1377696
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center